| Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery N Zahin, R Anwar, D Tewari, M Kabir, A Sajid, B Mathew, M Uddin, ... Environmental Science and Pollution Research 27 (16), 19151-19168, 2020 | 143 | 2020 |
| Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool J Jose, R Kumar, S Harilal, GE Mathew, DGT Parambi, A Prabhu, M Uddin, ... Environmental Science and Pollution Research 27 (16), 19214-19225, 2020 | 97 | 2020 |
| Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders MS Uddin, A Al Mamun, M Jakaria, S Thangapandiyan, J Ahmad, ... Science of the Total Environment 707, 135624, 2020 | 85 | 2020 |
| Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives S Harilal, J Jose, DGT Parambi, R Kumar, GE Mathew, MS Uddin, H Kim, ... Journal of Pharmacy and Pharmacology 71 (9), 1370-1383, 2019 | 85 | 2019 |
| Combination drug therapy for the management of Alzheimer’s disease MT Kabir, MS Uddin, AA Mamun, P Jeandet, L Aleya, RA Mansouri, ... International journal of molecular sciences 21 (9), 3272, 2020 | 84 | 2020 |
| Melatonin in Alzheimer’s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer’s neuropathology M Hossain, M Uddin, GM Uddin, DM Sumsuzzman, M Islam, GE Barreto, ... Molecular Neurobiology 56 (12), 8255-8276, 2019 | 84 | 2019 |
| Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases B Mathew, DGT Parambi, GE Mathew, MS Uddin, ST Inasu, H Kim, ... Archiv der Pharmazie 352 (11), 1900177, 2019 | 82 | 2019 |
| Cholinesterase inhibitors for Alzheimer's disease: multitargeting strategy based on anti-Alzheimer's drugs repositioning MT Kabir, M Uddin, M Begum, S Thangapandiyan, M Rahman, L Aleya, ... Current Pharmaceutical Design 25 (33), 3519-3535, 2019 | 82 | 2019 |
| Toxic tau: structural origins of tau aggregation in Alzheimer's disease A Al Mamun, MS Uddin, B Mathew, GM Ashraf Neural Regeneration Research 15 (8), 1417, 2020 | 80 | 2020 |
| Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology M Uddin, A Al Mamun, M Kabir, M Jakaria, B Mathew, GE Barreto, ... Molecular neurobiology 56 (7), 4925-4944, 2019 | 76 | 2019 |
| Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies B Mathew, GE Mathew, G Uçar, I Baysal, J Suresh, JK Vilapurathu, ... Bioorganic Chemistry 62, 22-29, 2015 | 76 | 2015 |
| Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ... International journal of biological macromolecules 91, 680-695, 2016 | 67 | 2016 |
| Molecular insight into the therapeutic promise of flavonoids against Alzheimer’s disease MS Uddin, MT Kabir, K Niaz, P Jeandet, C Clément, B Mathew, A Rauf, ... Molecules 25 (6), 1267, 2020 | 66 | 2020 |
| NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer's therapy MT Kabir, MA Sufian, M Uddin, M Begum, S Akhter, A Islam, B Mathew, ... Current Pharmaceutical Design 25 (33), 3506-3518, 2019 | 64 | 2019 |
| Heteroaryl chalcones: Mini review about their therapeutic voyage B Mathew, J Suresh, S Anbazghagan, J Paulraj, GK Krishnan Biomedicine & Preventive Nutrition 4 (3), 451-458, 2014 | 64 | 2014 |
| Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors R Sasidharan, SL Manju, G Uçar, I Baysal, B Mathew Archiv der Pharmazie 349 (8), 627-637, 2016 | 63 | 2016 |
| Estrogen signaling in Alzheimer’s disease: molecular insights and therapeutic targets for Alzheimer’s dementia M Uddin, M Rahman, M Jakaria, M Hossain, A Islam, M Ahmed, B Mathew, ... Molecular Neurobiology 57 (6), 2654-2670, 2020 | 56 | 2020 |
| Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO‐B Inhibitors B Mathew, A Haridas, G Uçar, I Baysal, M Joy, GE Mathew, ... ChemMedChem 11 (11), 1161-1171, 2016 | 55 | 2016 |
| Monoamine oxidase inhibitory action of chalcones: a mini review B Mathew, A Haridas, J Suresh, G E Mathew, G Uçar, V Jayaprakash Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2016 | 54 | 2016 |
| Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease MS Uddin, MT Kabir, D Tewari, B Mathew, L Aleya Science of the Total Environment 700, 134836, 2020 | 52 | 2020 |
Ghulam Md AshrafAssociate Professor, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, KSAVerified email at kau.edu.sa
